logo
Select company
Select metric
Ticker Information

Ticker

VIVS

Company Name

VIVOSIM LABS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIVOSIM LABS INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VIVS - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ -8.99M0%$ 142K
3/31/2025$ -8.99M0%$ 144K
12/31/2024$ 13K10.66%$ 122K
9/30/2024$ 13K12.62%$ 103K
6/30/2024$ 27K36.99%$ 73K
3/31/2024$ 42K38.53%$ 109K
12/31/2023$ 204K84.3%$ 242K
9/30/2023$ 245K66.58%$ 368K
6/30/2023$ 337K75.73%$ 445K
3/31/2023$ 396K107.03%$ 370K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOSIM LABS INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
  • Over the past 5 years, VIVOSIM LABS INC's average CapEx % has been 43.32%.
  • The median CapEx % for VIVOSIM LABS INC during this period was 32.13%
  • VIVOSIM LABS INC reached its highest CapEx % over the past 5 years at 107.03%.
  • The lowest CapEx % recorded by VIVOSIM LABS INC in the same timeframe 10.66%

VIVOSIM LABS INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
AIM : AIM IMMUNOTECH INC 248.76%SILO : SILO PHARMA INC -GLTO : GALECTO INC -DRMA : DERMATA THERAPEUTICS INC -ADTX : ADITXT INC -OGEN : ORAGENICS INC -HCWB : HCW BIOLOGICS INC 90.34%SLRX : SALARIUS PHARMACEUTICALS INC -TOVX : THERIVA BIOLOGICS INC -REVB : REVELATION BIOSCIENCES INC -

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for VIVOSIM LABS INC is calculated as follows: CapEx [ $ -727K ] / Revenues [ $ 298K ]
(=) CapEx % [ 0% ]

VIVS - Capital Expenditures Margin, Last 5 years

10.66%

Minimum

Dec 31, 2024

107.03%

Maximum

Mar 31, 2023

43.32%

Average

32.13%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.02%
average3.47%
median2.43%
std3.27%